Cargando…

Biologic treatment of Japanese patients with inflammatory bowel disease

BACKGROUND: There is little information regarding the use of biologics in Inflammatory Bowel Disease (IBD) patients in Japan. The aim of this study was to determine the factors associated with the use of biologics in the treatment of Japanese patients with IBD. METHODS: An online survey was conducte...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mahlich, Jörg, Matsuoka, Katsuyoshi, Sruamsiri, Rosarin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6211510/ https://www.ncbi.nlm.nih.gov/pubmed/30384833 http://dx.doi.org/10.1186/s12876-018-0892-x

Ejemplares similares

Preferences Regarding Shared Decision-Making in Japanese Inflammatory Bowel Disease Patients
por: Morishige, Ryuji, et al.
Publicado: (2016)

Persistence with biologic agents for the treatment of rheumatoid arthritis in Japan
por: Mahlich, Jörg, et al.
Publicado: (2016)

Co-insurance and health care utilization in Japanese patients with rheumatoid arthritis: a discontinuity regression approach
por: Mahlich, Jörg, et al.
Publicado: (2019)

Shared Decision-Making and Patient Satisfaction in Japanese Rheumatoid Arthritis Patients: A New “Preference Fit” Framework for Treatment Assessment
por: Mahlich, Jörg, et al.
Publicado: (2019)

The underrated prevalence of depression in Japanese patients with rheumatoid arthritis - evidence from a Nationwide survey in Japan
por: Sruamsiri, Rosarin, et al.
Publicado: (2017)

Persistence with Biological Disease-modifying Antirheumatic Drugs and Its Associated Resource Utilization and Costs
por: Sruamsiri, Rosarin, et al.
Publicado: (2018)

Hospitalization costs and length of stay of Japanese children with respiratory syncytial virus: A structural equation modeling approach
por: Sruamsiri, Rosarin, et al.
Publicado: (2018)

Persistence rates and medical costs of biological therapies for psoriasis treatment in Japan: a real-world data study using a claims database
por: Sruamsiri, Rosarin, et al.
Publicado: (2018)

Drug Utilization of Japanese Patients Diagnosed with Schizophrenia: An Administrative Database Analysis
por: Cheung, Stephane, et al.
Publicado: (2017)

Impact of patient characteristics and treatment procedures on hospitalization cost and length of stay in Japanese patients with influenza: A structural equation modelling approach
por: Sruamsiri, Rosarin, et al.
Publicado: (2017)

The relationship between socio-demographic factors, health status, treatment type, and employment outcome in patients with inflammatory bowel disease in Japan
por: Mahlich, J, et al.
Publicado: (2017)

Cultural beliefs, utility values, and health technology assessment
por: Mahlich, Jörg, et al.
Publicado: (2018)

Treatment patterns and healthcare resource utilization in palmoplantar pustulosis patients in Japan: A claims database study
por: Miyazaki, Celine, et al.
Publicado: (2020)

Diet, microbiota, and inflammatory bowel disease: lessons from Japanese foods
por: Kanai, Takanori, et al.
Publicado: (2014)

The gut microbiota and inflammatory bowel disease
por: Matsuoka, Katsuyoshi, et al.
Publicado: (2014)

NUDT15 gene variants and thiopurine-induced leukopenia in patients with inflammatory bowel disease
por: Matsuoka, Katsuyoshi
Publicado: (2020)

Real-World Insurance Claims Analysis of Venous Thromboembolism in Japanese Patients with Inflammatory Bowel Disease
por: Fujiya, Mikihiro, et al.
Publicado: (2022)

Persistence With Biologic Therapy and Associated Costs of Patients With Inflammatory Bowel Disease: A German Retrospective Claims Data Analysis
por: Mahlich, Joerg, et al.
Publicado: (2021)

Quality of Reporting of Randomised Controlled Trials of Herbal Interventions in ASEAN Plus Six Countries: A Systematic Review
por: Pratoomsoot, Chayanin, et al.
Publicado: (2015)

Adherence and rehospitalizations in patients with schizophrenia: evidence from Japanese claims data
por: Kuwabara, Hiroyo, et al.
Publicado: (2015)

Treatment pathways of Japanese prostate cancer patients - A retrospective transition analysis with administrative data
por: Cheung, Stephane, et al.
Publicado: (2018)

Cost of Illness of Japanese Patients with Chronic Lymphocytic Leukemia (CLL), and Budget Impact of the Market Introduction of Ibrutinib
por: Mahlich, Jörg, et al.
Publicado: (2017)

Policies and Programs to Facilitate Access to Targeted Cancer Therapies in Thailand
por: Sruamsiri, Rosarin, et al.
Publicado: (2015)

Biologic targeting in the treatment of inflammatory bowel diseases
por: Bosani, Matteo, et al.
Publicado: (2009)

Cost utility analysis of reduced intensity hematopoietic stem cell transplantation in adolescence and young adult with severe thalassemia compared to hypertransfusion and iron chelation program
por: Sruamsiri, Rosarin, et al.
Publicado: (2013)

Epidemiology and costs of dengue in Thailand: A systematic literature review
por: Thisyakorn, Usa, et al.
Publicado: (2022)

Sleep disturbances in Japanese patients with inflammatory bowel disease and their impact on disease flare
por: Uemura, Risa, et al.
Publicado: (2016)

Real-World Treatment Persistence with Biologic Disease-Modifying Antirheumatic Drugs Among German Patients with Psoriatic Arthritis—A Retrospective Database Study
por: Sewerin, Philipp, et al.
Publicado: (2021)

Anxiety and behavioral changes in Japanese patients with inflammatory bowel disease due to COVID-19 pandemic: a national survey
por: Nakase, Hiroshi, et al.
Publicado: (2023)

Biologic targeting in the treatment of inflammatory bowel diseases [Retraction]
Publicado: (2014)

Biosimilar biological drugs in the treatment of inflammatory bowel diseases
por: Kaniewska, Magdalena, et al.
Publicado: (2019)

Oral Delivery of Biologics in Inflammatory Bowel Disease Treatment
por: Zhang, Wunan, et al.
Publicado: (2021)

Modeling the Choice Between Risperidone Long-Acting Injectable and Generic Risperidone from the Perspective of a Japanese Hospital
por: Nakamura, Yusuke, et al.
Publicado: (2019)

Prevalence of Irritable Bowel Syndrome–like Symptoms in Japanese Patients with Inactive Inflammatory Bowel Disease
por: Tomita, Toshihiko, et al.
Publicado: (2016)

Oral Health in Patients with Inflammatory Bowel Diseases Qualified for Biologic Treatment
por: Nijakowski, Kacper
Publicado: (2022)

Risk of Nephrolithiasis in Patients with Inflammatory Bowel Disease Receiving Biologic Treatment
por: Alameddine, Zakaria, et al.
Publicado: (2023)

Clinical Effects of Thai Herbal Compress: A Systematic Review and Meta-Analysis
por: Dhippayom, Teerapon, et al.
Publicado: (2015)

Inflammatory Bowel Disease: An Overview of Immune Mechanisms and Biological Treatments
por: de Mattos, Bruno Rafael Ramos, et al.
Publicado: (2015)

The incidence and risk factors of venous thromboembolism in Japanese inpatients with inflammatory bowel disease: a retrospective cohort study
por: Ando, Katsuyoshi, et al.
Publicado: (2018)

Immunogenicity of biologics in inflammatory bowel disease
por: Vermeire, Séverine, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_tif8i2brgi8152vj602es3iss3